Paperpal Prime Logo

International Journal of Clinical Oncology : Impact Factor & More

eISSN: 1437-7772pISSN: 1341-9625

Key Metrics

CiteScore
5.3
H-Index
70
Impact Factor
< 5
SJR
Q1Surgery
SNIP
1.49
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on International Journal of Clinical Oncology

International Journal of Clinical Oncology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher SPRINGER JAPAN KK
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year1996
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in International Journal of Clinical Oncology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in International Journal of Clinical Oncology

Benefits of PARP inhibitor rechallenge in patients with platinum-sensitive recurrent ovarian cancer previously treated with a PARP inhibitor: a multicenter retrospective study.
  • 7 Aug 2026
  • International journal of clinical oncology
Effectiveness of anti-CD19 CAR T-cell therapy for high-grade B-cell lymphoma in Japan: a single-institution analysis.
  • 7 Aug 2026
  • International journal of clinical oncology
Pain response after palliative-intent radiotherapy for pancreatic cancer: a systematic review.
  • 7 Aug 2026
  • International journal of clinical oncology
Predictive value of TTF-1 expression for stratifying outcomes between dual ICI and chemoimmunotherapy in patients with PD-L1-negative NSCLC.
  • 4 Aug 2026
  • International journal of clinical oncology
Clinical utility and cost-effectiveness of universal tumor screening to identify Lynch syndrome in patients with stage II/III colorectal cancer: a prospective observational study in Japan.
  • 4 Aug 2026
  • International journal of clinical oncology
Olaparib maintenance versus placebo or standard of care in ovarian cancer: a biomarker-driven systematic review and meta-analysis of randomized trials.
  • 4 Aug 2026
  • International journal of clinical oncology
Benefits of PARP inhibitor rechallenge in patients with platinum-sensitive recurrent ovarian cancer previously treated with a PARP inhibitor: a multicenter retrospective study.
  • 7 Aug 2026
  • International journal of clinical oncology
Effectiveness of anti-CD19 CAR T-cell therapy for high-grade B-cell lymphoma in Japan: a single-institution analysis.
  • 7 Aug 2026
  • International journal of clinical oncology
Pain response after palliative-intent radiotherapy for pancreatic cancer: a systematic review.
  • 7 Aug 2026
  • International journal of clinical oncology
Predictive value of TTF-1 expression for stratifying outcomes between dual ICI and chemoimmunotherapy in patients with PD-L1-negative NSCLC.
  • 4 Aug 2026
  • International journal of clinical oncology
Clinical utility and cost-effectiveness of universal tumor screening to identify Lynch syndrome in patients with stage II/III colorectal cancer: a prospective observational study in Japan.
  • 4 Aug 2026
  • International journal of clinical oncology
Olaparib maintenance versus placebo or standard of care in ovarian cancer: a biomarker-driven systematic review and meta-analysis of randomized trials.
  • 4 Aug 2026
  • International journal of clinical oncology

FAQs on International Journal of Clinical Oncology